Venture Life Group plc (AIM:VLG)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 69.00
+1.00 (1.47%)
Nov 6, 2026, 4:33 PM GMT
Venture Life Group Market Cap
Venture Life Group has a market cap or net worth of 82.75 million as of November 6, 2026. It is the 24,185th most valuable company in the world and the 540th biggest in the United Kingdom. Its market cap has increased by 20.79% in one year.
Market Cap
82.75M
Enterprise Value
71.70M
Revenue
35.27M
Global Rank
Country Rank
#540 United Kingdom
PE Ratio
36.29
ChartMarket Cap Chart
Since March 28, 2014, Venture Life Group's market cap has increased from 26.08M to 82.75M, an increase of 217.24%. That is a compound annual growth rate of 9.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 80.35M | -3.77% |
| Dec 31, 2025 | 83.50M | 67.44% |
| Dec 31, 2024 | 49.87M | 17.68% |
| Dec 29, 2023 | 42.38M | -8.22% |
| Dec 30, 2022 | 46.17M | 22.31% |
| Dec 31, 2021 | 37.75M | -67.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.79B |
| GSK plc | 75.77B |
| Haleon | 30.01B |
| Smith & Nephew | 9.90B |
| Scancell Holdings | 101.58M |
| Bioventix | 100.84M |
| INSPECS Group | 96.62M |
| Allergy Therapeutics | 82.32M |